Thanks for sharing. I think there are some valid questions raised. One can pick weak points and perceived weak points in every technology if they want.
Just look at the results from one of the TCR companies he champions on his twitter page. The whole field has a long way to go and there will be a place and need for many technologies for many years to come.
https://pipelinereview.com/index.php/2022020480307/DNA-RNA-and-Cells/Medigene-reports-preliminary-efficacy-and-immune-monitoring-data-of-Phase-I-of-Phase-I/II-MDG1011-trial-in-blood-cancers.html
Guess we will find out some time later next year what Omnicar is capable of.
Ann: PTX unveils new clinic-ready CAR-T enhancement platform, page-90
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
